First Header Logo Second Header Logo

Connection

Mary Ann Thenganatt to Movement Disorders

This is a "connection" page, showing publications Mary Ann Thenganatt has written about Movement Disorders.
Connection Strength

2.034
  1. Thenganatt MA, Jankovic J. Psychogenic (Functional) Movement Disorders. Continuum (Minneap Minn). 2019 Aug; 25(4):1121-1140.
    View in: PubMed
    Score: 0.669
  2. Thenganatt MA, Jankovic J. Psychogenic movement disorders. Neurol Clin. 2015 Feb; 33(1):205-24.
    View in: PubMed
    Score: 0.490
  3. Thenganatt MA, Jankovic J. Parkinson disease subtypes. JAMA Neurol. 2014 Apr; 71(4):499-504.
    View in: PubMed
    Score: 0.462
  4. Thenganatt MA, Fahn S. Botulinum toxin for the treatment of movement disorders. Curr Neurol Neurosci Rep. 2012 Aug; 12(4):399-409.
    View in: PubMed
    Score: 0.412
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.